Home > Insider Trading > Filing (0001179110-21-010021)

Filing Details

Accession Number:: 0001179110-21-010021
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-11-09 20:57:52
Reporting Period:: 2021-11-05

Accepted Time:: 2021-11-09 20:57:52
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1551306	Progyny Inc.	PGNY	Services-Misc Health & Allied Services, Nec (8090)	272220139

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1789513	Jennifer Bealer	C/O Progyny, Inc. 1359 Broadway, 2Nd Fl New York NY 10018	Evp, General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2021-11-05	5,041	$64.66	66,590	No	4	S	Direct
Common Stock	Disposition	2021-11-05	1,700	$65.10	64,890	No	4	S	Direct
Common Stock	Disposition	2021-11-05	2,157	$66.28	62,733	No	4	S	Direct
Common Stock	Disposition	2021-11-05	981	$67.09	61,752	No	4	S	Direct
Common Stock	Disposition	2021-11-05	211	$68.06	61,541	No	4	S	Direct
Common Stock	Acquisiton	2021-11-08	30,000	$0.00	91,541	No	4	A	Direct
Common Stock	Disposition	2021-11-08	3,463	$64.61	88,078	No	4	S	Direct
Common Stock	Disposition	2021-11-08	11,499	$65.66	76,579	No	4	S	Direct
Common Stock	Disposition	2021-11-08	6,963	$66.55	69,616	No	4	S	Direct
Common Stock	Disposition	2021-11-08	200	$67.17	69,416	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	A	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Acquisiton	2021-11-08	115,000	$0.00	115,000	$66.66

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
115,000		2031-11-07	No	4	A	Direct

Footnotes

Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 28, 2021.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.51 to $65.47, inclusive.
The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2), (4), (5), (6), (8), (9), (10) and (11).
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.59 to $66.55, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.60 to $67.51, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.79 to $68.32, inclusive.
Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. One-fourth (1/4th) of the RSUs will vest on November 8, 2022 and the remainder of the shares will vest in equal quarterly installments thereafter through November 8, 2025, subject to the Reporting Person continuing to provide service through each such date.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.11 to $65.04, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.13 to $66.12, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.15 to $67.12, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.16 to $67.17, inclusive.
One-fourth (1/4th) of the shares subject to the option will vest November 8, 2022 and the remainder of the shares will vest in equal quarterly installments thereafter through November 8, 2025, subject to the Reporting Person continuing to provide service through each such date.